Table 1.

Prostaglandin production and VEGFA release in BCPs stimulated and not stimulated by cisplatin 30 μM in the absence or in the presence of 10 nM dexamethasone for 48 h.

Treatment	PGE2 Release (pg/mL) ± SD	VEGF Release (pg/mL) ± SD
None	78 ± 8.2	41.6 ± 3.8
Dexamethasone 10 nM	40.6 ± 5.3 *	32.3 ± 3.1 *
Cisplatin 30 μM	232.4 ± 21.6 *	131.6 ± 11.4 *
Cisplatin 30 μM + Dexamethasone 10 nM	108.5 9.1 §	78.1 ±6.9 §

Cell culture supernatants from BCPs in the absence (none treatment) and the presence of 30 mM cisplatin, with or without 10 nM dexamethasone, were assayed for PGE2 production and VEGFA release. Values are from three independent experiments (n = 3). The non-parametric Mann-Whitney test was used for pairwise comparisons. * p < 0.05 vs. cells without treatment; ^§  p < 0.05 vs. cells treated with cisplatin.